DarioHealth Corp. Files 8-K
Ticker: DRIO · Form: 8-K · Filed: Aug 25, 2025 · CIK: 1533998
| Field | Detail |
|---|---|
| Company | Dariohealth CORP. (DRIO) |
| Form Type | 8-K |
| Filed Date | Aug 25, 2025 |
| Risk Level | low |
| Pages | 4 |
| Reading Time | 5 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, filing
TL;DR
DarioHealth filed an 8-K on 8/25/25 for corporate changes.
AI Summary
DarioHealth Corp. filed an 8-K on August 25, 2025, reporting amendments to its articles of incorporation or bylaws, other events, and financial statements/exhibits. The company, formerly known as LabStyle Innovations Corp. until November 1, 2011, is incorporated in Delaware and headquartered in New York.
Why It Matters
This filing indicates DarioHealth Corp. is making changes to its corporate structure or governance, which could impact its operational framework and reporting.
Risk Assessment
Risk Level: low — The filing is a routine corporate disclosure and does not appear to contain significant negative financial or operational news.
Key Players & Entities
- DarioHealth Corp. (company) — Registrant
- LabStyle Innovations Corp. (company) — Former name
- November 1, 2011 (date) — Date of name change
- August 25, 2025 (date) — Date of report
- Delaware (jurisdiction) — State of incorporation
- New York (location) — Principal Executive Offices City
FAQ
What specific amendments were made to DarioHealth Corp.'s articles of incorporation or bylaws?
The filing indicates amendments were made, but the specific details of these amendments are not provided in the provided text.
What are the 'Other Events' reported by DarioHealth Corp. on August 25, 2025?
The filing mentions 'Other Events' as a category, but the specific nature of these events is not detailed in the provided text.
What is the significance of filing 'Financial Statements and Exhibits' in this 8-K?
This indicates that financial information and supporting documents are being submitted as part of the filing, likely related to the reported events or corporate changes.
When did DarioHealth Corp. change its name from LabStyle Innovations Corp.?
DarioHealth Corp. changed its name from LabStyle Innovations Corp. on November 1, 2011.
Where are DarioHealth Corp.'s principal executive offices located?
DarioHealth Corp.'s principal executive offices are located at 322 W 57th St., #33B, New York, New York 10019.
Filing Stats: 1,134 words · 5 min read · ~4 pages · Grade level 11.1 · Accepted 2025-08-25 16:05:55
Key Financial Figures
- $0.0001 — registered Common Stock, par value $0.0001 per share DRIO The Nasdaq Capital M
Filing Documents
- tm2524185d1_8k.htm (8-K) — 31KB
- tm2524185d1_ex3-1.htm (EX-3.1) — 10KB
- tm2524185d1_ex99-1.htm (EX-99.1) — 11KB
- 0001104659-25-082513.txt ( ) — 224KB
- drio-20250825.xsd (EX-101.SCH) — 3KB
- drio-20250825_lab.xml (EX-101.LAB) — 33KB
- drio-20250825_pre.xml (EX-101.PRE) — 22KB
- tm2524185d1_8k_htm.xml (XML) — 4KB
03 Amendments to Articles of Incorporation or By-Laws; Change in Fiscal Year
Item 5.03 Amendments to Articles of Incorporation or By-Laws; Change in Fiscal Year. Effective as of August 28, 2025, DarioHealth Corp. (the "Company") will effect a reverse stock split of its outstanding shares of common stock at a ratio of twenty -for- one (the "Reverse Split"). The Reverse Split, which was approved by the Company's board of directors under authority granted by the Company's stockholders at the Company's 2025 Annual Meeting of Stockholders held on July 23, 2025, was consummated pursuant to a Certificate of Amendment filed with the Secretary of State of Delaware on August 25, 2025 (the "Certificate of Amendment"). The Reverse Split will take effect on August 28, 2025. Effects of the Reverse Split Effective Date; Symbol; CUSIP Number . The Reverse Split will take effect at 12:01 a.m. Eastern Standard Time on August 28, 2025, and will be reflected with the Nasdaq Capital Market ("Nasdaq") and in the marketplace at the open of business on August 28, 2025 (the "Effective Date"), whereupon the shares of common stock will begin to trade on a split-adjusted basis. In connection with the Reverse Split, the Company's common stock will continue to trade on Nasdaq under the symbol "DRIO" but will trade under a new CUSIP Number, 23725P 308. Split Adjustment; No Fractional Shares . On the Effective Date, the total number of shares of the Company's common stock held by each shareholder will convert automatically into the number of whole shares of common stock equal to (i) the number of issued and outstanding shares of common stock held by such shareholder immediately prior to the Reverse Split, divided by (ii) twenty. No fractional shares will be issued, and no cash or other consideration will be paid. In lieu of any fractional shares, stockholders who would otherwise hold a fractional share because the number of shares of common stock they hold before the Reverse Split is not evenly divisible by the Reverse Split ratio that number of shares of common sto
01 Other Events
Item 8.01 Other Events. On August 25, 2025, the Company issued a press release titled "DarioHealth Announces 20-to-1 Reverse Stock Split." A copy of the press release is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits 3.1 Certificate of Amendment to the Company's Certificate of Incorporation to implement the Reverse Split. 99.1 Press release dated August 25, 2025. 104 Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: August 25, 2025 DARIOHEALTH CORP. By: /s/ Chen Franco-Yehuda Name: Chen Franco-Yehuda Title: Chief Financial Officer, Treasurer and Secretary